All Pharma News
price-trendAsk Us
Adcendo to Present Data on its Novel ADC Target uPARAP at the AACR Meeting 2024

Adcendo to Present Data on its Novel ADC Target uPARAP at the AACR Meeting 2024
PR NEWSWIRE
04 Apr 2024
Share Share
Adcendo, Duality Biologics to Further Expand First-in-Class ADC Pipeline

Adcendo, Duality Biologics to Further Expand First-in-Class ADC Pipeline
CONTRACT PHARMA
01 Jun 2023
Share Share
Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP
PR NEWSWIRE
13 Apr 2023
Share Share
Adcendo Announces Extension of Series A Financing to 82M EUR

Adcendo Announces Extension of Series A Financing to 82M EUR
PR NEWSWIRE
04 Apr 2023
Share Share
ADC biotech brings total Series A raise to $89M+; Takeda hands $40M to Arrowhead

ADC biotech brings total Series A raise to $89M+; Takeda hands $40M to Arrowhead
Tyler Patchen ENDPTS
04 Apr 2023
Share Share
Adcendo Announces Agreement with Duality Biologics on ADC Platform

Adcendo Announces Agreement with Duality Biologics on ADC Platform
PR NEWSWIRE
05 Jan 2023
Share Share
Adcendo presents Data on uPARAP targeting ADCs in Osteosarcoma PDX Models

Adcendo presents Data on uPARAP targeting ADCs in Osteosarcoma PDX Models
PRNEWSWIRE
11 Apr 2022
Share Share
GSK oncology head leaves for biotech Scorpion—Chutes & Ladders

GSK oncology head leaves for biotech Scorpion—Chutes & Ladders
Kyle LaHucik FIERCEBIOTECH
09 Jul 2021
Share Share
Ex-Immunomedics CEO takes the wheel at Danish ADC player

Ex-Immunomedics CEO takes the wheel at Danish ADC player
Amirah Al Idrus FIERCEBIOTECH
07 Jul 2021
Share Share